belimumab,rituximab
gsk
['rituximab', 'ritux', 'belimumab']
#eular2023 #op0290 heterogeneity in #sle is not only disease features but think of ancestry. data from bilag-br registry showed worse outcomes in people of black and south asian treated with either rituximab or belimumab (adjusted for deprivation index) 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏